What are the challenges in targeting cGAS for cancer therapy?
One of the main challenges is achieving the right balance of cGAS activation. Overactivation can lead to harmful inflammation, while underactivation may not produce a sufficient immune response. Additionally, the diverse roles of cGAS in different types of cells and tissues complicate the development of targeted therapies. Researchers are working to understand these complexities to create more precise and effective treatments.
